- Home
- / MiRXES
MiRXES
Total Funding
$81 M
MiRXES Summary
Company Summary
- Overview
- MiRXES is a biotech company focused on microRNA research and applications. It provides life science research and in vitro diagnostic (IVD) products. The company also offers a microRNA-based blood test for early detection of stomach cancer and a SARS-CoV-2 diagnostic test. MiRXES serves the medical, pharmaceutical, agricultural, and veterinary industries.
- Type
- Private
- Status
- Active
- Founded
- 2014
- HQ
- Singapore, SG | view all locations
- Website
- https://mirxes.com/
- Cybersecurity rating
Table of Contents
Key People
Zou Ruiyang, Co-Founder, Chief Technology Officer
Isaac Ho, Chief Investment Officer
Choo Beng Lor, Chief Financial Officer
LocationsView all
9 locations detected
Singapore HQ
Singapore
2 Tukang Innovation Grove, #09-02 JTC MedTech Hub
Cambridge, MA
United States
625 Massachusetts Ave
Hangzhou, Zhe Jiang Sheng
China
No 2, Block 4, 1F, Unit 16, Baiyang Road, Hangzhou Economic Development Zone
Tianjin, Tian Jin Shi
China
5th Floor, Zhongnan Building, 18# Haitaixilu
Hong Kong, Kowloon
Hong Kong
Suite 3512, 35th Floor, The Gateway Tower 5 Harbour City, Tsim Sha Tsui
Tokyo, Tokyo
Japan
10F, Hibiya Fort Tower, 1-1-1 Nishishinbashi, Minato City